Cite
SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
MLA
Nanjing Shi, et al. “SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.” Frontiers in Public Health, vol. 9, June 2021. EBSCOhost, https://doi.org/10.3389/fpubh.2021.668368.
APA
Nanjing Shi, Yetan Shi, Jingsi Xu, Yuexiu Si, Tong Yang, Mengting Zhang, Derry Minyao Ng, Xiangyuan Li, & Fei Xie. (2021). SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.668368
Chicago
Nanjing Shi, Yetan Shi, Jingsi Xu, Yuexiu Si, Tong Yang, Mengting Zhang, Derry Minyao Ng, Xiangyuan Li, and Fei Xie. 2021. “SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.” Frontiers in Public Health 9 (June). doi:10.3389/fpubh.2021.668368.